Accessing KRAS G12C for Cancer Treatment

In this downloadable slideset, Marwan Fakih, MD, reviews key concepts and the latest clinical trial data on targeting KRASG12C for the treatment of solid tumors.
Marwan Fakih, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.02 MB
Released: October 29, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Amgen

Related Content

From Clinical Care Options (CCO), download a PDF featuring expert discussion on using immunotherapy for patients with advanced HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 22, 2021

From Clinical Care Options (CCO), download a PDF featuring expert answers to clinician questions on using immunotherapy for patients with advanced HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 21, 2021

Downloadable slideset reviewing the latest therapeutic approaches for pancreatic cancer harboring BRCA mutations, from Clinical Care Options (CCO)

person default Dirk Arnold, MD, PhD Released: January 21, 2021

Downloadable CCO resource summarizing best practices for detection of RET gene alterations in lung and thyroid tumors

Released: January 21, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue